Opposing Association of Lung Neutrophils and PD-L1 Monocytes in Age-Related Severity of SARS-CoV-2 Infection.

Opposing Association of Lung Neutrophils and PD-L1 Monocytes in Age-Related Severity of SARS-CoV-2 Infection.

Publication date: Jun 01, 2026

Advanced age is a major determinant of adverse outcomes during acute infections, yet the immunological mechanisms by which aging alters immune regulation and shapes disease trajectories remain poorly understood. Using SARS-CoV-2 infection as a model of acute viral challenge, we investigated how aging alters myeloid responses in the lungs. Across infected mouse models and human cohorts, disease severity was associated with a pronounced shift in myeloid balance, characterized by an increased neutrophil-to-monocyte ratio. Neutrophils exhibited prolonged retention within the pulmonary microvasculature and formed large co-aggregates with monocytes. In parallel, severe disease was associated with a defect in classical monocyte activation in the lungs, notably through reduced PD-L1 upregulation. This defect was not observed in the circulation, indicating tissue-dependent dysregulation of inflammatory and regulatory markers. Aging further accentuated this imbalance. Both aged mice and elderly patients displayed a reduced proportion of PD-L1-expressing lung monocytes, despite enhanced pulmonary neutrophil recruitment. This age-associated alteration distinguished severe from non-severe disease and characterized a maladaptive myeloid response to acute viral challenge. Together, these findings identify impaired, compartment-specific myeloid immune regulation as a central feature of age-related vulnerability to severe infection. They highlight that tissue-dependent regulatory failure compounds inflammatory excess as a key determinant of disease outcome and suggest that restoring myeloid regulatory function may offer therapeutic benefit in older individuals during acute respiratory infections.

Open Access PDF

Concepts Keywords
Aging Aged
Classical Aged, 80 and over
Microvasculature Aging
Myeloid aging
Viral Animals
B7-H1 Antigen
B7-H1 Antigen
CD274 protein, human
COVID-19
COVID‐19
Disease Models, Animal
Female
Humans
infection severity
Lung
Male
Mice
Middle Aged
Monocytes
monocytes
Neutrophils
neutrophils
SARS-CoV-2

Semantics

Type Source Name
disease MESH SARS-CoV-2 Infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH infections
drug DRUGBANK Isoxaflutole
disease MESH respiratory infections
drug DRUGBANK Diethylstilbestrol
disease MESH Des
pathway REACTOME Hemostasis
drug DRUGBANK L-Citrulline
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
disease MESH inflammation
disease MESH viral infections
disease MESH lymphopenia
pathway REACTOME Innate Immune System
disease MESH acute respiratory distress syndrome
disease MESH death
disease MESH immunothrombosis
disease MESH strain
drug DRUGBANK Cefaclor
disease MESH CCL
drug DRUGBANK Iron
disease MESH cross infection
drug DRUGBANK Xylazine
drug DRUGBANK Ketamine
disease MESH PBS
disease MESH tremors
disease MESH hypothermia
disease MESH weight loss
disease MESH included
disease MESH hematological malignancies
disease MESH Disease Models Animal

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *